注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   EGFRVIII   

EGFRVIII

     
  • 产品详情
  • 实验流程
Product Information
Primary Accession NP_001333870.1
Species Human
Sequence Leu25-Ser378
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per µg by the LAL method.
Biological Activity Immobilized EGFRVIII[Biotin], His&Avi, Human (Cat.No.: Z03941) at 0.5 µg/ml (100 µl/Well) on streptavidin (5 µg/ml) precoated plate can bind Anti-EGFR VIII Anitibody, hFc Tag.
Expression System HEK293
Theoretical Molecular Weight 41.6 kDa
Formulation Lyophilized from a 0.22 µm filtered solution in PBS, (pH 7.4).
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 µg/ml.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
Additional Information
Target Background Epidermal growth factor receptor (EGFR) is a transmembrane protein. It can be activated by epidermal growth factor or transforming growth factor alpha (TGF-α). EGFR plays an important role in cell survival, proliferation and angiogenesis. EGFR is highly expressed in a variety of solid tumours. It is a common target for cancer therapy.
Protein Information
Research Areas

For Research Use Only. Not For Use In Diagnostic Procedures.

FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价